AstraZeneca said on Thursday it has received a notice in China over unpaid taxes related to the import of two cancer ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

The firm scrapped its £450m investment despite the government's offer of support, the government says.

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

Drugmaker AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales ...

Astrazeneca's revenue jumped 21 per cent last year as the pharmaceutical recorded broad growth across its key businesses.

AstraZeneca Plc reported better-than-expected profit and sales in the fourth quarter and forecast further gains as the UK drugmaker’s blockbuster cancer drugs offset weakened China sales.

AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter 2024. The London-listed company ...

The AstraZeneca PLC ADR AZN advanced 2.86% to $70.94 Wednesday, on what proved to be an all-around favorable trading session ...